Webinar Archives - The Medical Cannabis Clinicians Society

Date: 11 March 2026 | Time: 7:00pm (UK) | Register: Click to register now via Zoom

What happens when a patient comes into hospital, a hospice, or a care setting with a medical cannabis prescription? How should clinical teams respond, and what are the right steps to ensure safe, lawful, and compassionate care?

This webinar is designed to help answer those questions. A companion session to the Managing Medical Cannabis in Hospitals and Care Settings Guide, it supports cannabis-naïve clinicians and healthcare teams working across hospitals, hospices, and community services.

The session explores the safe, legal, and ethical management of cannabis-based medicinal products (CBPMs) in hospitals, hospices, and community care.

It explains how to apply existing legislation and professional standards to everyday practice, aligning with the Misuse of Drugs Regulations 2001, the Mental Capacity Act 2005, the Equality Act 2010, CQC standards, NICE guidance, and GMC prescribing requirements. The focus is on giving clinicians the confidence to manage CBPMs appropriately and deliver safe, compliant, and patient-centred care.

What you will learn

The current legal position on CBPMs in hospital, hospice, and care settings.
How to identify eligible patients and manage shared-care arrangements safely.
Best practice for storage, administration, and record-keeping of controlled drugs.
Perioperative and palliative-care considerations for patients using medical cannabis.
How to support patients and colleagues through evidence-based, non-stigmatising communication.
Where to find trusted resources and ongoing support from the Society.

Who it’s for

This session is designed for multidisciplinary healthcare teams involved in patient care and medicines management, including:

Hospital consultants, GPs, and clinical leads
Palliative and hospice care professionals
Pharmacy, anaesthetic, surgical, nursing, and medical teams
Allied health professionals across acute, community, and residential care settings
Managers and medicines governance leads seeking clarity on safe implementation

Registration

The webinar is free to attend. It will be recorded and made available to all registered participants who wish to watch in their own time.

Book your place

This 45-minute session will be followed by a 15-minute open Q&A with Dr Evan Lewis and Dr Dave Tang.

Places are free but limited, so register now to secure your spot and learn how to apply structured, evidence-informed dosing guidance in your clinical work.

Speakers

Dr Evan Lewis, Paediatric Neurologist & Clinical Neurophysiologist
Dr Evan Lewis is an Executive Committee member of the Society and a Paediatric Neurologist and Clinical Neurophysiologist specialising in epilepsy. He is the founder and director of the Neurology Centre of Toronto (NCT) and serves as an Assistant Professor in the Department of Paediatrics at the Hospital for Sick Children and the University of Toronto. Dr Lewis is internationally recognised for his clinical and academic contributions, and for his leadership in advancing safe, evidence-informed approaches to medical cannabis in paediatric neurology.

Dr David Tang, Consultant in Emergency Medicine
Dr David Tang sits on the Society’s Executive Committee and is a Consultant in Emergency Medicine with specialist expertise in musculoskeletal conditions, sports injuries, and chronic pain. His clinical practice bridges acute care and longer-term symptom management, and he brings valuable insight into how medical cannabis can support patients with complex or persistent pain presentations.

Date: Tuesday 24 February 2026 | Time: 7:00pm (UK) | Register: Click to register now via Zoom

Join The Medical Cannabis Clinicians Society and Curaleaf Laboratories for an in-depth exploration of emerging delivery systems for cannabis-based medicinal products (CBPMs). This webinar is designed for prescribers, pharmacists, nurses, and healthcare professionals involved in medical cannabis care.

As clinical practice evolves beyond traditional oil and flower preparations, new formulations – such as cartridges, capsules, pastilles, creams, and inhaler devices – offer diverse options for patients and prescribers alike. This session will examine the science, safety, and clinical application of these formats, with expert insight from three leading UK clinicians.

What you will learn

Pharmacokinetics, bioavailability, and onset profiles of alternative delivery systems
Considerations for dosing equivalence between oral, inhaled, and topical routes
Practical considerations for patient selection, adherence, and acceptability
Clinical use cases and emerging evidence for each formulation
Manufacturing standards and quality assurance within UK-licensed supply chains

This event builds on the Society’s aims to help healthcare professionals prescribe confidently, safely, and in line with best practice guidance.

Who should attend?

Doctors, pharmacists, nurses, and professionals involved in prescribing, dispensing, or advising on CBPMs who want to expand their knowledge of new delivery methods and clinical applications.

Register for Free

This 45-minute session will be followed by a 15-minute open Q&A with Dr Niraj Singh, Dr Rob Forbes, and Matthew Rawdings, Pharmacist from Curaleaf Laboratories.

This webinar is kindly supported by Curaleaf. We are grateful for their ongoing support of clinician education. If your organisation is interested in supporting the Society’s work, please get in touch.

Places are free but limited, so register now to secure your spot and learn how to apply structured, evidence-informed dosing guidance in your clinical work.

Speakers

Dr Niraj Singh, Consultant Psychiatrist
Dr Niraj Singh is an Executive Committee member and an experienced Consultant Psychiatrist specialising in depression, anxiety disorders, ADHD, and Autism. With a holistic clinical approach, he has a strong interest in emerging and alternative treatments. Dr Singh is committed to ensuring that patients who may benefit from medical cannabis receive safe, well-monitored access under specialist care.

Dr Rob Forbes, Consultant Anaesthetist

Dr Rob Forbes is an Executive Committee Member, Consultant Anaesthetist and Chronic Pain Specialist with over 20 years of experience. He has led local chronic pain services, developed primary care guidance, and managed complex pain syndromes. Since 2018, Dr Forbes has specialised in medicinal cannabis, co-founding Borders Pain Clinic and advocating for NHS access while educating professionals and supporting patient care initiatives.

Matty Rawding, Pharmacist
Matty Rawding is a member of the Society’s Executive Committee and a Medical Cannabis Specialist Pharmacist at Curaleaf Laboratories, the first UK facility to produce medical cannabis domestically. A practising pharmacist since 2019, he is completing a PhD in cannabinoid science at the University of Birmingham. Matty is recognised for his leadership in improving patient access, supporting prescribers, and shaping clinical understanding of medical cannabis across the UK.

Date: Thursday 15 January 2026 | Time: 7:00pm (UK) | Register: Click to register now via Zoom

In this practical session, Dr Evan Cole Lewis and Dr Rowan Thompson, editors of the new MCCS dosing guide for medical cannabis oils, will walk through the key principles of safe, effective oil-based prescribing. The webinar introduces clinicians to the frameworks set out in Medical Cannabis Oils: Dosing and Guidance for Safe and Effective Treatment in Adults and Children, the first comprehensive guide to dosing and titrating medical cannabis oils in the UK.

Across this focused hour, attendees will explore evidence-informed protocols for oil initiation, titration, monitoring, follow-up, and when to introduce THC. The session is designed to support clinicians in applying consistent, structured approaches to prescribing medical cannabis oils in real-world settings.

Developed by clinicians for clinicians, the new dosing guidance brings clarity, safety and consistency to an area that has, until now, lacked unified standards. Dr Evan Lewis and Dr Rowan Thompson will explain why structured oil dosing matters, how the handbook was developed, and how prescribers can use the framework to strengthen decision-making and improve patient outcomes. A must-attend for clinicians seeking practical, reliable tools for safe, defensible oil-based prescribing.

What you will learn

How to use the new MCCS dosing guide for medical cannabis oils
Step-by-step titration strategies, including start-low-go-slow principles
When and how to introduce THC safely
How to monitor, adjust and troubleshoot treatment over time
How structured dosing and titration improve safety, consistency and clinical outcomes
Practical tips for integrating the guidance into assessments, follow-up and documentation

Who should attend?

Open to all clinicians, including:

Specialist consultants, GPs, and independent prescribers
Pharmacists, nurses, AHPs and clinic managers

Register for Free
This 45-minute session will be followed by a 15-minute open Q&A with Dr Evan Lewis and Dr Rowan Thompson, giving attendees the opportunity to explore real-world dosing challenges, titration decisions, and safe prescribing practice in more depth.

Places are free but limited, so register now to secure your spot and learn how to apply structured, evidence-informed dosing guidance in your clinical work.

Date: Thursday 20 November 2025 | Time: 7:00pm (UK) | Register: Click to register now via Zoom

In this practical session, Professor Mike Barnes, Chair of the Medical Cannabis Clinicians Society (MCCS), will walk through the key principles of the Good Practice Guide for Prescribers of Cannabis-Based Medicinal Products (CBPMs) – the definitive framework for safe, ethical, and compliant prescribing in the UK. In this webinar, explore the updated guidance, including best practice in consultations, peer review, prescribing protocols, and follow-up care.

Developed by clinicians for clinicians, the Guide brings clarity and consistency to an evolving field. Professor Barnes will explain why the framework matters, how it aligns with GMC and MHRA expectations, and how prescribers can apply it to strengthen clinical practice and protect patients.

A must-attend for clinicians and clinic managers who want to ensure they meet professional standards and deliver safe, defensible care.

What you will learn

What defines good practice in medical cannabis prescribing
The role of the Good Practice Guide in ensuring consistency, safety, and accountability
How to apply the guidelines in clinical consultations, documentation, and shared care
The importance of peer review, outcome tracking, and ongoing professional development

Who should attend?

Open to all professionals working in or around medical cannabis prescribing, including:

Specialist consultants, GPs, and independent prescribers
Pharmacists, nurses, and clinic managers
Medical educators, regulators, and industry stakeholders

Register for Free
This 45-minute session will be followed by a 15-minute open Q&A with Professor Barnes, giving attendees the chance to ask questions and discuss real-world applications of the Good Practice framework.

Places are free but limited – register now to secure your spot and join the conversation on raising standards in medical cannabis prescribing.